Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

cell and gene therapy

  • Advanced Therapies,Clinical & Regulatory

    UK experts urge Government to appoint Minister for cell and gene therapies

    Commission sets out 25 policy recommendations to unlock access and [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain

    Unlocking collective intelligence: Why cell and gene therapy needs a data-sharing revolution

    Alexander Seyf, CEO of Autolomous, explains how collaboration—not competition—is the [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain

    Is Europe rising? How global pharma uncertainty is fuelling a new era for European innovation

    As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]

    May 5, 2026
  • Advanced Therapies,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain

    Inside CTMC: Innovating cell therapy development from patient to clinic

    Cell therapy has emerged as one of the most promising [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    Digital shift aims to fix long-term gaps in cell and gene therapy trials

    Medable unveils a patient-first remote model to support 15-year safety [...]

    May 5, 2026
  • Advanced Therapies

    Powerhouse partnership targets faster path to gene therapies

    eXmoor Pharma and KU Leuven team up to launch CGT [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    ReiThera to showcase AAV breakthroughs and expand US reach

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Title21 appoints expert committee to support cell and gene therapy platform development

    May 5, 2026
  • Advanced Therapies

    Astraveus teams up with NecstGen to trial benchtop CAR-T manufacturing platform

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business

    Cellevate consortium secures €1M Eurostars grant to boost iPSC manufacturing at scale

    May 5, 2026
Previous34

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Newron completes Phase 3 trial enrolment in schizophrenia
    Categories: Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Personalised cancer medicine: closing the clinical trial access gap
    Categories: Clinical & Regulatory, Digital & Data, Genomics and sequencing, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Formation Bio launches $600M drug development fund
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top